𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical Study of Autologous Cytokine-Induced Killer Cells for the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma

✍ Scribed by Xue-chun Lu; Bo Yang; Rui-li Yu; Xiao-hua Chi; Shuai Tuo; Chao-wei Tuo; Hong-li Zhu; Yao Wang; Chao-guang Jiang; Xiao-bing Fu; Yang Yang; Yang Liu; Shan-qian Yao; Han-ren Dai; Li-li Cai; Bing-jun Li; Wei-dong Han

Book ID
107567878
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
470 KB
Volume
62
Category
Article
ISSN
1085-9195

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of a THP-COP regimen fo
A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma
✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly

Doxorubicin-based chemotherapy for diffu
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients : Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
✍ Keun-Wook Lee; Dae-Young Kim; Tak Yun; Dong-Wan Kim; Tae-You Kim; Sung-Soo Yoon; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 2 views

## BACKGROUND. Although many studies of elderly patients with non-Hodgkin lymphoma have focused on the dose intensity of chemotherapy, few studies have restricted the histologic inclusion criteria such that only patients with diffuse large B-cell lymphoma (DLCL) are considered. In the current stud